Farxiga is indicated to [Select All That Apply]:
 
a. improve blood sugar control along with diet and exercise in adults with type 2 diabetes.
b. reduce the risk of hospitalization for heart failure in adults with type 2 diabetes.
c. reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
d. reduce the risk of diabetic ketoacidosis in adults with type 1 diabetes.

Answer: (a,b,c)
 
The active ingredient found in Farxiga is Dapagliflozin (Farxiga).  Farxiga is indicated to:
 
1. improve blood sugar control along with diet and exercise in adults with type 2 diabetes.
2. reduce the risk of hospitalization for heart failure in adults with type 2 diabetes.
3. reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
 
Farxiga should not be used to treat people with type 1 diabetes or diabetic ketoacidosis (increased ketones in your blood or urine).
 
To improve glycemic control, the recommended starting dose of Farxiga is 5 mg orally once daily, taken in the morning, with or without food. In patients tolerating Farxiga 5 mg once daily who require additional glycemic control, the dose can be increased to 10 mg once daily.